DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••• B••••••••• S•••• F••••• I••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: A••• B••••••••• S•••• Parent, LP
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 100¢ · 100¢ · 100¢ · 100¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
100¢100¢
Principal held
at least $42.6M
sum of BDC pieces, a lower bound
Fair value
$42.0M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
3
2 equity pieces beside them
Next maturity
Feb 5, 2031
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Jun 30, 2026
Events
4
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A••••• D••• S•••••••• B•• | $25.2M | 100¢ | 0 pts |
| M••••• F•••••••• I••••••••• C••• | $17.4M | 100¢ | 0 pts |
Every BDC piece · 10 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••••• D••• S•••••••• B•• | term loan first lien Investment T••• F•••• L••• S•••••• D••• - T••• L••• I••••••• R••• S+500, 1.00% F•••• M•••• | $14.7M | $14.5M 100c | SOFR+500 bp |
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• - T••• L••• S•••+500, 1.00% F•••• M••••••• D••• 02/05/32 | $10.5M | $10.4M 100c | SOFR+500 bp |
| A••••• D••• S•••••••• B•• | delayed draw term loan first lien Investment T••• F•••• L••• S•••••• D••• - D•••••• D••• I••••••• R••• S+500, 1.00% F•••• M• | $10.5M | $10.3M 100c | SOFR+500 bp |
| M••••• F•••••••• I••••••••• C••• | delayed draw term loan first lien F•••• L••• S•••••• D••• – D•••••• D••• S•••+500, 1.00% F•••• M••••••• D••• 02/05/32 | $6.9M | $6.8M 100c | SOFR+500 bp |
| A••••• D••• S•••••••• B•• | equity equity Investment T••• C••••• Equity - S•••• | Not disclosed | $1,000 100c |
View all 10 positionsShow fewerlargest principal first
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••••• D••• S•••••••• B•• | preferred equity equity Investment T••• P•••••••• Equity - P•••••••• S••••• | Not disclosed | $99,000 100c | |
| A••••• D••• S•••••••• B•• | revolver first lien Investment T••• F•••• L••• S•••••• D••• - R••••••• I••••••• R••• S+500, 1.00% F•••• M••••• | Not disclosed | $-107,000 92c | SOFR+500 bp |
| M••••• F•••••••• I••••••••• C••• | equity equity C••••• Equity - C••••• S•••• | Not disclosed | $1,000 100c | |
| M••••• F•••••••• I••••••••• C••• | revolver first lien F•••• L••• S•••••• D••• – R••••••• S•••+500, 1.00% F•••• M••••••• D••• 02/05/31 | Not disclosed | $-34,000 87c | SOFR+500 bp |
| M••••• F•••••••• I••••••••• C••• | preferred equity equity P•••••••• Equity - P•••••••• Equity | Not disclosed | $99,000 100c |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $25.2M | 100c | SOFR+500 bp | Feb 5, 2032 | 2 |
| first lien delayed draw term loan first lien | at least $17.4M | 100c | SOFR+500 bp | Feb 5, 2032 | 2 |
| first lien revolver first lien | unknown | n/a | SOFR+500 bp | Feb 5, 2031 | 2 |
Equity pieces beside the debt: preferred equity ($198,000 fair value, 2 BDCs), equity ($2,000 fair value, 2 BDCs)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $42.6M | $41.8M | 100c | 0 |
| Mar 31, 2026 | 2 | $42.7M | $41.7M | 100c | 0 |
| Dec 31, 2025 | 2 | $25.4M | $24.4M | 99c | 0 |
| Sep 30, 2025 | 2 | $25.5M | $24.5M | 99c | 0 |
All 6 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | $25.5M | $24.5M | 99c | 0 |
| Mar 31, 2025 | 2 | $25.5M | $24.7M | 100c | 0 |
What changed
- Spread changed (observed)Jun 30, 2026
- Spread changed (observed)Jun 30, 2026
- Spread changed (observed)Jun 30, 2026
- New borrower on a BDC scheduleMar 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- AVID BIOSERVICES SPACEderivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 2 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it